| Financial Year |
March 31 2023 |
| Monetary Funds |
2,878,181,703.86 |
| Held-for-trading Financial Assets |
217,001,182.00 |
| Notes Receivable |
57,879,960.18 |
| Accounts Receivable |
2,256,212,990.69 |
| Advances to Suppliers |
90,595,828.56 |
| Other Receivables |
71,189,216.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
747,273,111.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,507,791.68 |
| Total Current Assets |
6,566,820,968.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
133,109,883.49 |
| Investment Properties |
-- |
| Fixed Assetes |
405,798,966.02 |
| Under-construction Projects |
61,158,627.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
188,643,076.16 |
| R&D expenses |
33,697,526.99 |
| Goodwill |
432,343,985.70 |
| Long-Term Deferred and Prepaid Expenses |
7,291,572.34 |
| Deferred Income Tax Assets |
45,409,487.75 |
| Other Non-Current Assets |
32,137,568.19 |
| Sub-Total of Non-Current Assets |
1,388,044,460.30 |
| Total Assets |
7,954,865,429.00 |
| Short-Term Loans |
460,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,510,523.30 |
| Accounts Payable |
729,690,265.65 |
| Accounts Received In Advance |
60,970,544.26 |
| Employee Compensation Payable |
78,593,905.49 |
| Taxes Payable |
65,941,451.94 |
| Interest Payable |
121,656.11 |
| Dividend Payable |
-- |
| Other payables |
137,645,415.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,309,033.01 |
| Other Current Liabilities |
19,973,966.90 |
| Sub-Total of Current Liabilities |
1,676,290,318.23 |
| Long-term Loans |
96,145,996.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,206,410.68 |
| Deferred Income Tax Liabilities |
42,978,177.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
180,009,861.73 |
| Total Liabilities |
1,856,300,179.96 |
| Paid-In Capital(Or Share Stock) |
564,795,437.00 |
| Capital Surplus |
2,461,106,857.83 |
| Surplus Reserve |
218,165,890.81 |
| LESS:Treasury Stock |
52,844,681.66 |
| Undistributed Profits |
2,706,638,558.84 |
| Minority Stockholder's Interest |
204,945,000.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,893,620,248.38 |
| Owner's Equity（Stockholder's Equity） |
6,098,565,249.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,954,865,429.00 |
